Prescription profile and safety of oral capecitabine in metastatic colorectal cancer patients

• In: Poster presentation
• At: Buenos Aires (Argentina) (2016)
• Type: Poster
• Poster code: POS-HPS-025
• By: FERNáNDEZ BARRANTES, Cristina (Caja Costarricense de Seguro Social/ Hospital San Juan de Dios, Drug Information Center, San José, Costa Rica)
• Co-author(s): Angelina Zumbado Arroyo:Pharmacy Service,Caja Costarricense de Seguro Social/ Hospital San Juan de Dios,San José,Costa Rica|Cristina Fernández Barrantes:Drug Information Center,Caja Costarricense de Seguro Social/ Hospital San Juan de Dios,San José,Costa Rica
  
• Abstract:

  Capecitabine is an oral fluoropyrimidine effective in the treatment of metastatic colorectal cancer, has a toxicity profile well established. The most common adverse reactions reported are hand-foot syndrome, diarrhea, stomatitis, nausea and vomiting. Capecitabine is generally considered well tolerated.

  Observacional retrospective study, based on a

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login